IMOGAM RABIES PASTEURIZED human rabies immunoglobulin 150 IU/mL injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

imogam rabies pasteurized human rabies immunoglobulin 150 iu/ml injection vial

sanofi-aventis australia pty ltd - rabies immunoglobulin, quantity: 150 iu/ml - injection - excipient ingredients: glycine; sodium chloride; water for injections - imogam rabies pasteurized is indicated in subjects who are thought to have been exposed to rabies virus, especially cases of major exposure, in accordance with w.h.o. recommendations as specified in the international product information.

VaxigripTetra Suspension for injection in pre-filled syringe Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

vaxigriptetra suspension for injection in pre-filled syringe

sanofi pasteur, france - influenza a virus a/indonesia/5/2005 (h5n1) antigen (uv, formaldehyde inactivated) - suspension for injection in pre-filled syringe - 15 µg,

Humenza European Union - English - EMA (European Medicines Agency)

humenza

sanofi pasteur s.a. - split influenza virus, inactivated, containing antigen*: a/california/7/2009 (h1n1)v like strain (x-179a)*propagated in eggs. - influenza, human; immunization; disease outbreaks - vaccines - prophylaxis of influenza in an officially declared pandemic situation.pandemic influenza vaccine should be used in accordance with official guidance.

Procomvax European Union - English - EMA (European Medicines Agency)

procomvax

sanofi pasteur msd, snc - polyribosylribitol phosphate from haemophilus influenzae type b as prp-ompc, outer membrane protein complex of neisseria meningitidis (outer membrane protein complex of the b11 strain of neisseria meningitidis subgroup b), adsorbed hepatitis b surface antigen produced in recombinant yeast cells (saccharomyces cerevisiae) - hepatitis b; meningitis, haemophilus; immunization - vaccines - procomvax is indicated for vaccination against invasive disease caused by haemophilus influenzae type b and against infection caused by all known subtypes of hepatitis b virus in infants 6 weeks to 15 months of age.,

VERORAB VACCINE Powder and solvent for suspension for injection in pre-filled syringe Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

verorab vaccine powder and solvent for suspension for injection in pre-filled syringe

sanofi pasteur, france - rabies virus strain pm-1503-3m antigen (propiolactone inactivated) - powder and solvent for suspension for injection in pre-filled syringe - 2.5 iu

HEXAXIM vaccine Suspension for injection Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

hexaxim vaccine suspension for injection

sanofi pasteur, france - diphtheria toxoid,tetanus toxoid,pertussis toxoid,haemagglutinin,inactivated polio virus (ipv) type 1,inactivated polio virus (ipv) type 2,inactivated polio virus (ipv) type 3,hepatitis b virus hbsag surface antigen,haemophilus influenzae type b - suspension for injection - 20,40,25,25,40,8,32,10,12 iu, µg, da